Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q4 2025 investor letter. A ...

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...

National Museums Scotland and National Galleries of Scotland are to join forces to create a joint “national collections hub” ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

Palo Alto Networks, Inc. is rated Hold with revenue growth remains resilient, driven by SASE, XSIAM. Learn more about PANW ...

The outcome of the Bears/Rams Divisional Round clash might not have been one that fans wanted, but the touchdown that sent ...

Charles River Laboratories will pay $60 million for the remaining shares of PathoQuest and $510 million for acquiring K.F.

The FDA released a draft guidance document that provides a regulatory framework for sponsors to utilize minimal residual ...

Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnings Per Share by Approximately $0.25 in 2026 and Approximately $0.60 in 2027 –– Exercises Option to ...

The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...

Securing the backing from big investors including the Future Fund and several superannuation giants will allow the company to ...

SHANGHAI and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- Oricell Therapeutics Holdings Limited ("Oricell" or "the Company"), a global leader in innovative cancer immunotherapy, announced today the ...